Published in N Engl J Med on July 21, 1983
Predictors of successful aging: a twelve-year study of Manitoba elderly. Am J Public Health (1991) 2.19
Nonionic contrast media: economic analysis and health policy development. CMAJ (1989) 2.13
Monitoring the diffusion of a technology: coronary artery bypass surgery in Ontario. Am J Public Health (1988) 1.86
National health insurance in America--can we practice with it? Can we continue to practice without it? West J Med (1989) 1.30
Allocation of health care resources: a challenge for the medical profession. CMAJ (1986) 1.00
Lessons from the frozen North. West J Med (1989) 0.98
Who administers? Who cares? Medical administrative and clinical employment in the United States and Canada. Am J Public Health (1996) 0.95
Effects of global budgeting on the distribution of dentists and use of dental care in Taiwan. Health Serv Res (2004) 0.86
Containing Ontario's hospital costs under universal insurance in the 1980s: what was the record? CMAJ (1990) 0.85
Transitional funding: changing Ontario's global budgeting system. Health Care Financ Rev (1992) 0.82
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) (2000) 22.00
Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol (1993) 18.09
Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder and hand) [corrected]. The Upper Extremity Collaborative Group (UECG) Am J Ind Med (1996) 16.45
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med (1991) 10.55
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ (1992) 10.40
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet (2013) 8.16
Outcome measures for low back pain research. A proposal for standardized use. Spine (Phila Pa 1976) (1998) 6.51
Screening for prostate cancer. A decision analytic view. JAMA (1994) 5.83
Measuring disease-specific quality of life in clinical trials. CMAJ (1986) 5.56
Meta-analysis in clinical research. Ann Intern Med (1987) 5.16
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
Shopping around for hospital services: a comparison of the United States and Canada. JAMA (1998) 4.41
What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21
Multidisciplinary rehabilitation for chronic low back pain: systematic review. BMJ (2001) 4.06
Waiting times for knee-replacement surgery in the United States and Ontario. N Engl J Med (1994) 3.96
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis (2004) 3.95
Health-related quality of life after knee replacement. J Bone Joint Surg Am (1998) 3.88
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53
Screening for colon cancer--can we afford colonoscopy? N Engl J Med (2001) 3.48
Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res (1996) 3.40
Criteria for rheumatic disease. Different types and different functions. The American College of Rheumatology Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum (1994) 3.24
The MACTAR Patient Preference Disability Questionnaire--an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol (1987) 3.13
Direct and indirect costs of asthma in Canada, 1990. CMAJ (1996) 3.07
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
Evaluating changes in health status: reliability and responsiveness of five generic health status measures in workers with musculoskeletal disorders. J Clin Epidemiol (1997) 2.92
Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology (1989) 2.88
Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med (1982) 2.74
What do we know about the reliability and validity of physical examination tests used to examine the upper extremity? J Hand Surg Am (1999) 2.65
Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev (2002) 2.65
Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment. Ann Intern Med (1991) 2.61
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis (2004) 2.60
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA (2001) 2.49
The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun (2005) 2.47
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Comparison of a generic (SF-36) and a disease specific (WOMAC) (Western Ontario and McMaster Universities Osteoarthritis Index) instrument in the measurement of outcomes after knee replacement surgery. J Rheumatol (1995) 2.23
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles. OMERACT Committee. J Rheumatol (1993) 2.14
Preference for endpoint measures in clinical trials: results of structured workshops. J Rheumatol (1983) 2.13
Nonionic contrast media: economic analysis and health policy development. CMAJ (1989) 2.13
Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13
Preventing disability from work-related low-back pain. New evidence gives new hope--if we can just get all the players onside. CMAJ (1998) 2.12
When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med (1985) 2.11
A randomized crossover trial of Quick Medical Reference (QMR) as a teaching tool for medical interns. J Gen Intern Med (1994) 2.10
Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial. Am J Med (1986) 2.08
Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med (1986) 2.08
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med (1995) 2.07
Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med (1997) 2.04
Socioeconomic factors affecting the utilization of surgical operations. N Engl J Med (1977) 2.02
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
A systematic review of the prognosis of acute whiplash and a new conceptual framework to synthesize the literature. Spine (Phila Pa 1976) (2001) 1.99
The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis (2004) 1.92
Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making (1997) 1.84
Ontario patients' acceptance of waiting times for knee replacements. J Rheumatol (1994) 1.80
Biomechanical and psychosocial risk factors for low back pain at work. Am J Public Health (2001) 1.78
Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. N Engl J Med (1981) 1.72
Exercise for treating fibromyalgia syndrome. Cochrane Database Syst Rev (2002) 1.69
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
A methodological framework to develop and select indices for clinical trials: statistical and judgmental approaches. J Rheumatol (1983) 1.66
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64
Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) (2000) 1.64
Osteoarthritis of the hip and knee and mechanical occupational exposure--a systematic overview of the evidence. J Rheumatol (1997) 1.62
Perioperative parenteral nutrition: a meta-analysis. Ann Intern Med (1987) 1.62
Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ (1999) 1.61
Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum (1999) 1.59
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results. Med Decis Making (1997) 1.57
Systematic reviews of low back pain prognosis had variable methods and results: guidance for future prognosis reviews. J Clin Epidemiol (2009) 1.57
Classification systems of soft tissue disorders of the neck and upper limb: do they satisfy methodological guidelines? J Clin Epidemiol (1996) 1.56
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet (1990) 1.56
Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler (2008) 1.55
Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial. Arthritis Rheum (1989) 1.55
A randomized controlled trial to assess the incidence of new onset hypertension in patients after shock wave lithotripsy for asymptomatic renal calculi. J Urol (1998) 1.54
Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med (1997) 1.53
Tentative guidelines for using clinical and economic evaluations revisited. CMAJ (1993) 1.53
Variation in orthopedic surgeons' perceptions of the indications for and outcomes of knee replacement. CMAJ (1995) 1.51
Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51
The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med (1997) 1.50
Clinical and population epidemiology: beyond sibling rivalry? J Clin Epidemiol (1990) 1.49
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49
Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr (1984) 1.46
Should ERCP be routine after an episode of "idiopathic" pancreatitis? A cost-utility analysis. Gastrointest Endosc (1996) 1.41
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study. Arthritis Care Res (Hoboken) (2012) 1.40
Universal hepatitis B vaccination: the economics of prevention. CMAJ (1992) 1.40
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. Arch Intern Med (1990) 1.40
Primer on medical decision analysis: Part 5--Working with Markov processes. Med Decis Making (1997) 1.39
Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis. J Gen Intern Med (1990) 1.39
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis Rheum (1999) 1.38
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol (2000) 1.37
Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. J Hand Ther (2000) 1.36
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
Regional variation in medical care. N Engl J Med (1995) 1.35
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34